Genetic Engineering
Explore This Topic
The Environment (Protection) Act, 1986, Section 6, empowers the Central Government to make rules to regulate environmental pollution. Pursuant to this, the Ministry of Environment, Forest and Climate Change (MoEFCC) notified the 'Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells, 1989'. These rules are the primary legal…
Quick Summary
Genetic engineering is the direct manipulation of an organism's genetic material using advanced biotechnological tools. It fundamentally differs from traditional breeding by allowing precise, targeted changes to DNA sequences, enabling the introduction, removal, or modification of specific genes.
The core principle revolves around recombinant DNA (rDNA) technology, which involves cutting DNA with restriction enzymes, joining desired gene fragments with a vector using DNA ligase, and introducing this recombinant molecule into a host cell for replication and expression.
This foundational technique has been revolutionized by gene editing tools like CRISPR-Cas9, which offers unprecedented precision by using a guide RNA to direct the Cas9 enzyme to a specific DNA target, where it makes a double-strand break, allowing for gene knockout or insertion through cellular repair pathways.
Applications of genetic engineering are vast and transformative. In medicine, it underpins the production of biopharmaceuticals (e.g., insulin, vaccines), the development of gene therapies to correct genetic defects (e.
g., CAR-T cell therapy for cancer), and advanced diagnostics. In agriculture, it leads to genetically modified (GM) crops with enhanced traits such as pest resistance (Bt Cotton), herbicide tolerance, and improved nutritional value (Golden Rice), contributing to food security and sustainable farming.
Industrially, engineered microorganisms produce enzymes, biofuels, and biomaterials. India's regulatory framework, primarily governed by the GEAC under the Environment (Protection) Act, 1986, ensures biosafety and ethical oversight, balancing innovation with public and environmental protection.
Ethical considerations, particularly concerning human germline editing and biosafety, remain central to the ongoing discourse surrounding this powerful technology.
- Genetic Engineering: Direct manipulation of genes.
- rDNA Technology: Cut (restriction enzymes), Paste (DNA ligase), Insert (vector).
- CRISPR-Cas9: Guide RNA + Cas9 enzyme for precise gene editing.
- PAM Sequence: Essential for Cas9 binding (e.g., NGG).
- NHEJ: Error-prone repair, leads to gene knockout.
- HDR: Precise repair, leads to gene insertion/correction.
- Base Editing: Single base change without DSB.
- Prime Editing: Precise insertions/deletions/all 12 base changes without DSB.
- Gene Therapy: Introduce genes to treat disease.
- Somatic Gene Therapy: Non-heritable changes.
- Germline Gene Therapy: Heritable changes (controversial).
- Transgenic Organisms: Contain foreign DNA.
- Bt Cotton: Pest-resistant GM crop (India approved 2002).
- Golden Rice: Vitamin A enriched GM crop (controversial).
- NexCAR19: India's first indigenous CAR-T cell therapy (approved 2023).
- CAR-T Therapy: Genetically engineered T cells for cancer.
- GEAC: Genetic Engineering Appraisal Committee (MoEFCC).
- RCGM: Review Committee on Genetic Manipulation (DBT).
- IBSC: Institutional Biosafety Committee.
- Rules 1989: Primary legal framework for GE in India.
- Biosafety Guidelines 2022: For gene-edited plants, exempts SDN-1/2.
- Article 47: State's duty to improve public health.
- Article 48A: Protection of environment.
- Bioethics: Ethical concerns of biotechnology.
- Biosafety: Measures to protect from GE risks.
- Off-target effects: Unintended edits by gene-editing tools.
- Vectors: Deliver genetic material (plasmids, viruses).
- DNA Ligase: Joins DNA fragments.
- Restriction Enzymes: Cuts DNA at specific sites.
CRISPR-MAGIC: C - Cas9 Enzyme: The molecular scissors. R - RNA Guide: Directs Cas9 to target. I - Insert/Inactivate: Primary outcomes (HDR/NHEJ). S - Specificity: High precision gene editing. P - PAM Sequence: Essential for Cas9 binding.
R - Regulatory Bodies: GEAC, RCGM, IBSC. M - Medical Applications: Gene therapy, CAR-T, biopharma. A - Agricultural Applications: GM crops, pest/drought resistance. G - Germline vs. Somatic: Ethical distinction.
I - India's Framework: Rules 1989, Biosafety Guidelines 2022. C - Current Affairs: NexCAR19, GEAC approvals.
Related Topics
- Sci 07 01 01 Recombinant Dna Technologycontains
- Sci 07 01 04 Gene Therapycontains
- Sci 07 01 02 Gene Cloningcontains
- Sci 07 01 03 Crispr Technologycontains
- Sci 07 Biotechnologypart_of
- Sci 07 02 Medical Biotechnologyrelated_to
- Sci 07 05 Bioethics And Biosafetyrelated_to
- Sci 07 04 Industrial Biotechnologyrelated_to